Clinical Trials
Amgen announced that results from the PRIME ‘203’ and...
Amgen announced that results from the PRIME '203' and '181' pivotal Phase 3 trials evaluating Vectibix(R) (panitumumab) in combination with chemotherapy (FOLFOX or FOLFIRI) as...
Clinical Trials
Bristol-Myers Squibb announced results from a randomized, double-blind Phase...
Bristol-Myers Squibb Company and AstraZeneca announced results from a randomized, double-blind Phase 3 clinical study in adults with type 2 diabetes inadequately controlled on metformin...
Subscribe
- Never miss a story with notifications
- Gain full access to our premium content
- Browse free from any location or device.